This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Karo Pharma Bilan de santé
Santé financière contrôle des critères 1/6
Informations clés
104.8%
Ratio d'endettement
SEK 8.65b
Dette
Ratio de couverture des intérêts | 0.2x |
Argent liquide | SEK 353.10m |
Fonds propres | SEK 8.26b |
Total du passif | SEK 10.24b |
Total des actifs | SEK 18.49b |
Mises à jour récentes de la santé financière
Karo Pharma (STO:KARO) Has No Shortage Of Debt
Oct 14Is Karo Pharma (STO:KARO) A Risky Investment?
Jul 10Karo Pharma (STO:KARO) Seems To Be Using A Lot Of Debt
Mar 23Recent updates
Karo Pharma (STO:KARO) Has No Shortage Of Debt
Oct 14Is Karo Pharma (STO:KARO) A Risky Investment?
Jul 10Karo Pharma (STO:KARO) Seems To Be Using A Lot Of Debt
Mar 23Karo Pharma's (STO:KARO) Strong Earnings Are Of Good Quality
Feb 24Is Karo Pharma AB (publ)'s (STO:KARO) 1.5% ROE Worse Than Average?
Feb 22Did You Participate In Any Of Karo Pharma's (STO:KARO) Fantastic 144% Return ?
Feb 01Analyse de la situation financière
Passif à court terme: KARO's short term assets (SEK1.7B) exceed its short term liabilities (SEK626.0M).
Passif à long terme: KARO's short term assets (SEK1.7B) do not cover its long term liabilities (SEK9.6B).
Historique et analyse du ratio d'endettement
Niveau d'endettement: KARO's net debt to equity ratio (100.5%) is considered high.
Réduire la dette: KARO's debt to equity ratio has increased from 59.5% to 104.8% over the past 5 years.
Couverture de la dette: KARO's debt is not well covered by operating cash flow (5.9%).
Couverture des intérêts: KARO's interest payments on its debt are not well covered by EBIT (0.2x coverage).